Fingerprint
Dive into the research topics of 'Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first–line treatment of metastatic colorectal cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
G. Weldon Gilcrease, David D. Stenehjem, Mark L. Wade, John Weis, Kimberly McGregor, Jonathan Whisenant, Kenneth M. Boucher, Kelli Thorne, Nicole Orgain, Ignacio Garrido-Laguna, Sunil Sharma
Research output: Contribution to journal › Article › peer-review